Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Pfizer Inc
Pfizer Inc And Renovis Inc
Pfizer Inc Products Inc
Pfizer Inc Pfizer Products Inc

Pfizer Inc patents (2016 archive)

Recent patent applications related to Pfizer Inc. Pfizer Inc is listed as an Agent/Assignee. Note: Pfizer Inc may have other listings under different names/spellings. We're not affiliated with Pfizer Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pfizer Inc-related inventors

Date Pfizer Inc patents (2016 archive) (updated weekly) - BOOKMARK this page
12/29/16Prostate-associated antigens and vaccine-based immunotherapy regimens
12/29/16Compositions and methods for treating intracerebral hemorrhage
12/29/16Substituted dihydroisoquinolinone compounds
12/22/16Novel pyridine pyrazinones as bet-family bromodomain inhibitors
12/22/164-1bb binding molecules
12/15/16Glucagon receptor modulators
12/01/16N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/01/16Bicyclic-fused heteroaryl or aryl compounds
12/01/16Neisseria meningitidis composition and methods thereof
11/17/16Process for annealing amorphous atorvastatin
11/10/16Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
11/10/16Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
11/10/16Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
10/27/16Anti-estrogenic compounds
10/20/16Diacylglycerol acyltransferase 2 inhibitors
10/13/16Chimeric antigen receptors targeting b-cell maturation antigen
10/13/16Therapeutic antibodies and their uses
09/22/16Bifunctional cytotoxic agents containing the cti pharmacophore
09/22/16Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
09/22/16Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use
09/15/16Apixaban liquid formulations
09/01/16Intermediates and methods for synthesizing calicheamicin derivatives
08/25/16Apixaban formulations
08/25/16Substituted nucleoside derivatives useful as anticancer agents
08/18/16Vectors for expression of prostate-associated antigens
08/11/16Novel bicyclic pyridinones as gamma-secretase modulators
08/04/16Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris
08/04/16Combination therapy for tuberculosis
08/04/16N-acylpyrrolidine ether tropomyosin-related kinase inhibitors
08/04/16Novel cyclopropabenzofuranyl pyridopyrazinediones
07/21/16Crizotinib for use in the treatment of cancer
07/21/16Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr
07/21/16Therapeutic antibody
07/14/16Oral delivery product
07/14/16Heteroaromatic compounds and their use as dopamine d1 ligands
07/07/16Recombinant virus-like particles encoded by multi-gene vector
07/07/16Recombinant virus-like particles encoded by multi-gene vector
06/30/16Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
06/30/16Solid forms of a transthyretin dissociation inhibitor
06/23/16Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction
06/23/16Modified polysaccharides for conjugate vaccines
06/23/16Axl inhibitors
06/23/16Antagonists of prostaglandin ep3 receptor
06/02/16Enhanced stability of novel liquid compositions
06/02/162-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
06/02/16Antibodies to cd40
06/02/16Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
06/02/16Treatment with anti-pcsk9 antibodies
05/19/16Cold therapy device
05/19/16Use of a tetrasubstituted pyrazolo[4, 3-d]pyrimidine compound for treating diabetic nephropathy
05/12/16Sulfonyl amide derivatives for the treatment of abnormal cell growth
05/05/16Fecal recovery assay
04/28/16Solid forms of a macrocyclic kinase inhibitor
04/21/16Oligomers targeting hexanucleotide repeat expansion in human c9orf72 gene
04/14/16Substituted amide compounds
04/07/16Antibodies to insulin-like growth factor i receptor
03/31/16Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
03/03/16Substituted amide compounds
03/03/16Cancer treatment
02/25/16Aminopyrimidinyl compounds
02/18/16Pyrrolo[2,3-d]pyrimidine derivatives
02/18/16Rorc2 inhibitors and methods of use thereof
02/11/16Imidazopyridazine compounds
02/11/16Humanized antibodies specific for staphylococcal enterotoxin b
02/04/16Neisseria meningitidis compositions and methods thereof
01/28/16Spliceostatin analogs and methods for their preparation
01/28/16Novel pyrido[1,2-a]pryazines and their use in the treatment of neurodegenerative and neurological disorders
01/21/16Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators
01/21/16Indole and indazole compounds that activate ampk
01/21/16Immunogenic fusion polypeptides
01/21/16Indole and indazole compounds that activate ampk
01/14/16Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
01/07/16Solid forms of a selective cdk4/6 inhibitor
01/07/16Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
01/07/16Bispecific heterodimeric diabodies and uses thereof
01/07/16Saccharides and uses thereof

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Pfizer Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by